User login
Article Type
Changed
Thu, 12/15/2022 - 18:29
Display Headline
PARP Inhibitors: Usurping DNA Repair to Target Cancer
The emerging role for PARP inhibitors in BRCA-mutated cancers is reviewed by Community Oncology Editor-in-Chief Dr. Lee Schwartzberg.
Editor-in-Chief Lee S. Schwartzberg, M.D., is the research medical director at The West Clinic in Memphis, TN.
Topics
The emerging role for PARP inhibitors in BRCA-mutated cancers is reviewed by Community Oncology Editor-in-Chief Dr. Lee Schwartzberg.
Editor-in-Chief Lee S. Schwartzberg, M.D., is the research medical director at The West Clinic in Memphis, TN.
The emerging role for PARP inhibitors in BRCA-mutated cancers is reviewed by Community Oncology Editor-in-Chief Dr. Lee Schwartzberg.
Editor-in-Chief Lee S. Schwartzberg, M.D., is the research medical director at The West Clinic in Memphis, TN.
Topics
Article Type
Display Headline
PARP Inhibitors: Usurping DNA Repair to Target Cancer
Display Headline
PARP Inhibitors: Usurping DNA Repair to Target Cancer
Article Source
PURLs Copyright
Inside the Article